Cargando…
The Adapted POM Analysis of Avenanthramides In Silico
POM analysis and related approaches are significant tools based on calculating various physico-chemical properties and predicting biological activity, ADME parameters, and toxicity of a molecule. These methods are used to evaluate a molecule’s potential to become a drug candidate. Avenanthramides (A...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224542/ https://www.ncbi.nlm.nih.gov/pubmed/37242500 http://dx.doi.org/10.3390/ph16050717 |
_version_ | 1785050220217761792 |
---|---|
author | Maliar, Tibor Maliarová, Mária Purdešová, Andrea Jankech, Timotej Gerhardtová, Ivana Beňovič, Patrik Dvořáček, Václav Jágr, Michal Viskupičová, Jana |
author_facet | Maliar, Tibor Maliarová, Mária Purdešová, Andrea Jankech, Timotej Gerhardtová, Ivana Beňovič, Patrik Dvořáček, Václav Jágr, Michal Viskupičová, Jana |
author_sort | Maliar, Tibor |
collection | PubMed |
description | POM analysis and related approaches are significant tools based on calculating various physico-chemical properties and predicting biological activity, ADME parameters, and toxicity of a molecule. These methods are used to evaluate a molecule’s potential to become a drug candidate. Avenanthramides (AVNs) are promising secondary metabolites specific to Avena spp. (oat). They comprise the amides of anthranilic acid linked to various polyphenolic acids with or without post-condensation molecule transformation. These natural compounds have been reported to exert numerous biological effects, including antioxidant, anti-inflammatory, hepatoprotective, antiatherogenic, and antiproliferative properties. To date, almost 50 various AVNs have been identified. We performed a modified POM analysis of 42 AVNs using MOLINSPIRATION, SWISSADME, and OSIRIS software. The evaluation of primary in silico parameters revealed significant differences among individual AVNs, highlighting the most promising candidates. These preliminary results may help coordinate and initiate other research projects focused on particular AVNs, especially those with predicted bioactivity, low toxicity, optimal ADME parameters, and promising perspectives. |
format | Online Article Text |
id | pubmed-10224542 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102245422023-05-28 The Adapted POM Analysis of Avenanthramides In Silico Maliar, Tibor Maliarová, Mária Purdešová, Andrea Jankech, Timotej Gerhardtová, Ivana Beňovič, Patrik Dvořáček, Václav Jágr, Michal Viskupičová, Jana Pharmaceuticals (Basel) Article POM analysis and related approaches are significant tools based on calculating various physico-chemical properties and predicting biological activity, ADME parameters, and toxicity of a molecule. These methods are used to evaluate a molecule’s potential to become a drug candidate. Avenanthramides (AVNs) are promising secondary metabolites specific to Avena spp. (oat). They comprise the amides of anthranilic acid linked to various polyphenolic acids with or without post-condensation molecule transformation. These natural compounds have been reported to exert numerous biological effects, including antioxidant, anti-inflammatory, hepatoprotective, antiatherogenic, and antiproliferative properties. To date, almost 50 various AVNs have been identified. We performed a modified POM analysis of 42 AVNs using MOLINSPIRATION, SWISSADME, and OSIRIS software. The evaluation of primary in silico parameters revealed significant differences among individual AVNs, highlighting the most promising candidates. These preliminary results may help coordinate and initiate other research projects focused on particular AVNs, especially those with predicted bioactivity, low toxicity, optimal ADME parameters, and promising perspectives. MDPI 2023-05-09 /pmc/articles/PMC10224542/ /pubmed/37242500 http://dx.doi.org/10.3390/ph16050717 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Maliar, Tibor Maliarová, Mária Purdešová, Andrea Jankech, Timotej Gerhardtová, Ivana Beňovič, Patrik Dvořáček, Václav Jágr, Michal Viskupičová, Jana The Adapted POM Analysis of Avenanthramides In Silico |
title | The Adapted POM Analysis of Avenanthramides In Silico |
title_full | The Adapted POM Analysis of Avenanthramides In Silico |
title_fullStr | The Adapted POM Analysis of Avenanthramides In Silico |
title_full_unstemmed | The Adapted POM Analysis of Avenanthramides In Silico |
title_short | The Adapted POM Analysis of Avenanthramides In Silico |
title_sort | adapted pom analysis of avenanthramides in silico |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224542/ https://www.ncbi.nlm.nih.gov/pubmed/37242500 http://dx.doi.org/10.3390/ph16050717 |
work_keys_str_mv | AT maliartibor theadaptedpomanalysisofavenanthramidesinsilico AT maliarovamaria theadaptedpomanalysisofavenanthramidesinsilico AT purdesovaandrea theadaptedpomanalysisofavenanthramidesinsilico AT jankechtimotej theadaptedpomanalysisofavenanthramidesinsilico AT gerhardtovaivana theadaptedpomanalysisofavenanthramidesinsilico AT benovicpatrik theadaptedpomanalysisofavenanthramidesinsilico AT dvoracekvaclav theadaptedpomanalysisofavenanthramidesinsilico AT jagrmichal theadaptedpomanalysisofavenanthramidesinsilico AT viskupicovajana theadaptedpomanalysisofavenanthramidesinsilico AT maliartibor adaptedpomanalysisofavenanthramidesinsilico AT maliarovamaria adaptedpomanalysisofavenanthramidesinsilico AT purdesovaandrea adaptedpomanalysisofavenanthramidesinsilico AT jankechtimotej adaptedpomanalysisofavenanthramidesinsilico AT gerhardtovaivana adaptedpomanalysisofavenanthramidesinsilico AT benovicpatrik adaptedpomanalysisofavenanthramidesinsilico AT dvoracekvaclav adaptedpomanalysisofavenanthramidesinsilico AT jagrmichal adaptedpomanalysisofavenanthramidesinsilico AT viskupicovajana adaptedpomanalysisofavenanthramidesinsilico |